Back to Business

Ultragenyx gets FDA approval for rare disease gene therapy

Business September 17, 2026 at 7:10 PM

Ultragenyx gets FDA approval for rare disease gene therapy

Investing.com

Read at Investing.com

More Stories

Spot gold set to snap three-day losing streak a day after Fed’s rate hike

Spot gold set to snap three-day losing streak a day after Fed’s rate hike

🇺🇸 Investing.com 10m ago

Oramed Pharmaceuticals shareholders approve board, stock plan amendment at annual meeting

Oramed Pharmaceuticals shareholders approve board, stock plan amendment at annual meeting

🇺🇸 Investing.com 11m ago

FDA approves Ultragenyx’s Fayuvi for Sanfilippo syndrome Type A

FDA approves Ultragenyx’s Fayuvi for Sanfilippo syndrome Type A

🇺🇸 Investing.com 11m ago

Your world briefing, in your pocket

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play